Tango Therapeutics, Inc (TNGX)
20.22
-1.93 (8.71%)
Upcoming Events
Latest Headlines
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 5, 2026 7:00 AM - StreetInsider
Form 8-K Tango Therapeutics, Inc. For: Jun 04
June 4, 2026 5:19 PM - SEC Filing
Form 4 Tango Therapeutics, Inc. For: Jun 01 Filed by: Crystal Adam
June 3, 2026 6:37 PM - SEC Filing
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC
May 15, 2026 4:31 PM - SEC Filing
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Nextech Crossover I GP S.a r.l.
May 15, 2026 4:31 PM - SEC Filing
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Woodline Partners LP
May 15, 2026 9:17 AM - SEC Filing
Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: RTW INVESTMENTS, LP
May 15, 2026 8:34 AM - SEC Filing
Piper Sandler Downgrades Tango Therapeutics Inc. (TNGX) to Neutral
May 15, 2026 3:10 AM - StreetInsider
Tango Therapeutics Inc. (TNGX) PT Raised to $30 at Mizuho
May 14, 2026 4:13 PM - StreetInsider
Tango Therapeutics Inc. (TNGX) PT Raised to $55 at Leerink Partners
May 14, 2026 2:40 PM - StreetInsider
Jefferies Downgrades Tango Therapeutics Inc. (TNGX) to Hold
May 14, 2026 2:53 AM - StreetInsider
Form 8-K Tango Therapeutics, Inc. For: May 13
May 13, 2026 4:17 PM - SEC Filing
Form 10-Q Tango Therapeutics, Inc. For: Mar 31
May 13, 2026 4:16 PM - SEC Filing
Tango Therapeutics, Inc. (TNGX) Misses Q1 EPS by 1c
May 13, 2026 4:08 PM - StreetInsider
Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
May 13, 2026 4:07 PM - Globe NewsWire
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
May 13, 2026 9:18 AM - SEC Filing
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P.
May 11, 2026 8:49 AM - SEC Filing
Form 8-K Tango Therapeutics, Inc. For: May 07
May 8, 2026 9:22 AM - SEC Filing
Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: FMR LLC
May 6, 2026 11:41 AM - SEC Filing
Form 4 Tango Therapeutics, Inc. For: May 01 Filed by: Crystal Adam
May 5, 2026 7:47 PM - SEC Filing
Form 4 Tango Therapeutics, Inc. For: May 01 Filed by: Gall Matthew
May 5, 2026 7:47 PM - SEC Filing
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 4, 2026 4:31 PM - StreetInsider
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Invus Global Management, LLC
May 4, 2026 2:39 PM - SEC Filing
Tango Therapeutics, Inc (TNGX) May 23 and 30 calls active, share price up 10%
May 4, 2026 2:27 PM - StreetInsider
Form 4 Tango Therapeutics, Inc. For: Apr 29 Filed by: Lee Sung
May 1, 2026 5:27 PM - SEC Filing
Form 144 Tango Therapeutics, Inc. Filed by: Crystal Adam
May 1, 2026 4:49 PM - SEC Filing
Tango Therapeutics, Inc (TNGX) 2900 contracts of June 30 calls trade, share price down 5.5%
April 28, 2026 2:37 PM - StreetInsider
Tango Therapeutics Inc. (TNGX) PT Raised to $40 at Stifel on Higher PRMT5 Inhibitor Conviction
April 27, 2026 6:04 AM - StreetInsider
Form 3 Tango Therapeutics, Inc. For: Apr 15 Filed by: Gall Matthew
April 24, 2026 4:15 PM - SEC Filing
Form 3 Tango Therapeutics, Inc. For: Apr 15 Filed by: Newcomb Jessica
April 24, 2026 4:15 PM - SEC Filing
Stifel on Tango Therapeutics Inc. (TNGX): 'We have been consistently bullish'
April 20, 2026 12:17 PM - StreetInsider
Form ARS Tango Therapeutics, Inc. For: Dec 31
April 17, 2026 7:44 AM - SEC Filing
Form DEFA14A Tango Therapeutics, Inc.
April 17, 2026 7:42 AM - SEC Filing
Form DEF 14A Tango Therapeutics, Inc. For: Apr 16
April 17, 2026 7:12 AM - SEC Filing
Form 4 Tango Therapeutics, Inc. For: Apr 15 Filed by: Crystal Adam
April 16, 2026 8:14 PM - SEC Filing
Form 8-K Tango Therapeutics, Inc. For: Apr 10
April 15, 2026 9:19 AM - SEC Filing
Tango Therapeutics names Matthew Gall CFO, adds two executives
April 15, 2026 9:05 AM - StreetInsider
Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat
April 15, 2026 9:05 AM - StreetInsider
Tango Therapeutics Inc. (TNGX) PT Raised to $28 at Leerink Partners
April 13, 2026 4:09 PM - StreetInsider
Bernstein on US Pharma and Biotech: Who might buy whom?
April 13, 2026 5:52 AM - StreetInsider
Form 4 Tango Therapeutics, Inc. For: Apr 01 Filed by: Crystal Adam
April 2, 2026 8:09 PM - SEC Filing
Canaccord Starts Tango Therapeutics Inc. (TNGX) at Buy
April 2, 2026 5:12 AM - StreetInsider
Form 4 Tango Therapeutics, Inc. For: Mar 25 Filed by: Crystal Adam
March 27, 2026 8:07 PM - SEC Filing
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: VANGUARD GROUP INC
March 27, 2026 1:32 PM - SEC Filing
Tango Therapeutics Inc. (TNGX) PT Raised to $21 at B.Riley
March 27, 2026 4:56 AM - StreetInsider
Form 144 Tango Therapeutics, Inc. Filed by: Crystal Adam
March 25, 2026 4:25 PM - SEC Filing
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology
March 19, 2026 11:00 AM - StreetInsider
Tango Therapeutics Inc. (TNGX) PT Raised to $20 at Mizuho
March 11, 2026 6:35 AM - StreetInsider
Form 4 Tango Therapeutics, Inc. For: Mar 05 Filed by: Crystal Adam
March 9, 2026 4:01 PM - SEC Filing
Tango Therapeutics Inc. (TNGX) PT Raised to $24 at Stifel After Model Update
March 9, 2026 7:55 AM - StreetInsider
Full Article List
